Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
- PMID: 27608811
- PMCID: PMC5203762
- DOI: 10.1093/ijnp/pyw080
Antidepressant Effects of (+)-MK-801 and (-)-MK-801 in the Social Defeat Stress Model
Abstract
Background: Current data on antidepressant action of the N-methyl-D-aspartate receptor antagonist, (+)-MK-801, is inconsistent. This study was conducted to examine the effects of (+)-MK-801 and its less potent stereoisomer, (-)-MK-801, in the social defeat stress model of depression.
Methods: The antidepressant effects of (+)-MK-801 (0.1mg/kg) and (-)-MK-801 (0.1mg/kg) in the social defeat stress model were examined.
Results: In the tail suspension and forced swimming tests, both stereoisomers significantly attenuated increased immobility time in susceptible mice. In the sucrose preference test, (+)-MK-801, but not (-)-MK-801, significantly enhanced reduced sucrose consumption 2 or 4 days after a single dose. However, no antianhedonia effects were detected 7 days after a single dose of either stereoisomer.
Conclusions: Both stereoisomers of MK-801 induced rapid antidepressant effects in the social defeat stress model, although neither produced a long-lasting effect (7 days).
Keywords: MK-801; NMDA receptor; antidepressant; ketamine; stereoisomer.
© The Author 2016. Published by Oxford University Press on behalf of CINP.
Figures


Similar articles
-
Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.Psychopharmacology (Berl). 2016 Oct;233(19-20):3647-57. doi: 10.1007/s00213-016-4399-2. Epub 2016 Aug 4. Psychopharmacology (Berl). 2016. PMID: 27488193 Free PMC article.
-
NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.J Psychopharmacol. 2010 Apr;24(4):585-94. doi: 10.1177/0269881109104845. Epub 2009 Apr 7. J Psychopharmacol. 2010. PMID: 19351802
-
Involvement of NMDA receptors and L-arginine-nitric oxide pathway in the antidepressant-like effects of zinc in mice.Behav Brain Res. 2003 Sep 15;144(1-2):87-93. doi: 10.1016/s0166-4328(03)00069-x. Behav Brain Res. 2003. PMID: 12946598
-
Brain NMDA Receptors in Schizophrenia and Depression.Biomolecules. 2020 Jun 23;10(6):947. doi: 10.3390/biom10060947. Biomolecules. 2020. PMID: 32585886 Free PMC article. Review.
-
[Receptor antagonist of NMDA and animal models of schizophrenia].Fa Yi Xue Za Zhi. 2009 Dec;25(6):443-6. Fa Yi Xue Za Zhi. 2009. PMID: 20225623 Review. Chinese.
Cited by
-
Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions.Biomolecules. 2019 Nov 18;9(11):746. doi: 10.3390/biom9110746. Biomolecules. 2019. PMID: 31752219 Free PMC article.
-
Zanos et al. reply.Nature. 2017 Jun 21;546(7659):E4-E5. doi: 10.1038/nature22085. Nature. 2017. PMID: 28640272 Free PMC article. No abstract available.
-
The N-methyl-d-aspartate receptor hypothesis of ketamine's antidepressant action: evidence and controversies.Philos Trans R Soc Lond B Biol Sci. 2024 Jul 29;379(1906):20230225. doi: 10.1098/rstb.2023.0225. Epub 2024 Jun 10. Philos Trans R Soc Lond B Biol Sci. 2024. PMID: 38853549 Free PMC article. Review.
-
Neuromodulatory roles of PIPER GUINEENSE and honey against Lead-Induced neurotoxicity in social interactive behaviors and motor activities in rat models.AIMS Neurosci. 2022 Nov 15;9(4):460-478. doi: 10.3934/Neuroscience.2022026. eCollection 2022. AIMS Neurosci. 2022. PMID: 36660078 Free PMC article.
-
Mechanisms of ketamine action as an antidepressant.Mol Psychiatry. 2018 Apr;23(4):801-811. doi: 10.1038/mp.2017.255. Epub 2018 Mar 13. Mol Psychiatry. 2018. PMID: 29532791 Free PMC article. Review.
References
-
- Domino EF. (2010) Taming the ketamine tiger. 1965. Anesthesiology 113:678–684. - PubMed
-
- Haj-Mirzaian A, Kordjazy N, Haj-Mirzaian A, Ostadhadi S, Ghasemi M, Amiri S, Faizi M, Dehpour A. (2015) Evidence for the involvement of NMDA receptors in the antidepressant-like effect of nicotine in mouse forced swimming and tail suspension tests. Psychopharmacology (Berl) 232:3551–3561. - PubMed
-
- Hashimoto K. (2009) Emerging role of glutamate in the pathophysiology of major depressive disorder. Brain Res Rev 61:105–123. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical